Document is current
Any future updates will be listed below
-
Authors
Seminario, Gisela
Gonzalez-Serrano, Maria Edith
Aranda, Carolina Sanchez
Grumach, Anete Sevciovic
Segundo, Gesmar Rodrigues Silva
Regairaz, Lorena
Cardona, Aristoteles Alvares
,
Becerra, Juan Carlos Aldave
Poli, Cecilia
King, Alejandra
Fernandes, Fatima Rodrigues
Leiva, Lily
Franco, Jose Luis
Espinosa-Rosales, Francisco Javier
Sorensen, Ricardo
Costa Carvalho, Beatriz Tavares
Bezrodnik, Liliana
Condino-Neto, Antonio
-
Funding
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Fundação de Amparo à Pesquisa do Estado de São Paulo
Jeffrey Modell Foundation
CSL Behring, Brazil
- License Information
-
More Information
Article History
Received: 9 May 2024
Accepted: 1 October 2024
First Online: 22 October 2024
Declarations
:
: ASG has received research funding from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and researcher initiative grants from Takeda. She received fees for educational activities or as a consultant for Catalyst Pharmaceuticals, CSL Behring, Takeda, Kalvista, Pharvaris, Pint-Pharma, Multicare, and BioMarin. ACN declare receiving speaker's fees and participating in advisory boards for Takeda, CSL Behring, Novartis, AstraZeneca, GSK, and Sanofi Genzyme and research funding from Takeda and CSL Behring. FJES, GS, LB, LL, LR, declare no conflict of interest.
Free to read: This content has been made available to all.
